Rediti M, Fimereli D, Mileva M, Wimana Z, et al. Integrating molecular imaging and transcriptomic profiling in advanced HER2-positive breast cancer receiving trastuzumab emtansine (T-DM1): an analysis of the ZEPHIR clinical trial. Clin Cancer Res 2024 Oct 29. doi: 10.1158/1078-0432.CCR-24-1007.
PMID: 39470686